Bleomycin is a glycopeptide antibiotic used to treat human cancer.

the verdict

SUPPORTED

the evidence backs this

Recorded sources

5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Bleomycin is a glycopeptide antibiotic used to treat human cancer?

Yes. Bleomycin is a well-established antibiotic and chemotherapeutic agent utilized in treating various human cancers, including germ cell tumors and lymphomas.

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked 4 Oct 2026

The analysis

The retrieved papers consistently describe bleomycin as an antibiotic medication with anticancer properties used in standard chemotherapy regimens for human cancers such as lymphomas and germ cell tumors. There is no contradictory evidence regarding this pharmacological classification and clinical use.

Evidence for · 5

Bleomycin lung toxicity: who are the patients with increased risk?

2005

Get citation

Azambuja, E., Fleck, J., Batista, R. G., & Barreto, S. S. M. (2005). Bleomycin lung toxicity: who are the patients with increased risk?. doi.org. https://doi.org/10.1016/J.PUPT.2005.01.007

See more details

More for · 4

Role of Reactive Oxygen Species and Nitric Oxide in Mediating Chemotherapeutic Drug Induced Bystander Response in Human Cancer Cells Exposed In-Vitro

2012

Get citation

Chinnadurai, M., Rao, B. S., Deepika, R., Paul, S., & Venkatachalam, P. (2012). Role of Reactive Oxygen Species and Nitric Oxide in Mediating Chemotherapeutic Drug Induced Bystander Response in Human Cancer Cells Exposed In-Vitro. doi.org. https://doi.org/10.4021/wjon474w

Protocol-Stipulated Dose Modification to Manage Chemotherapy Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults with High-Risk Hodgkin Lymphoma

2024

Get citation

Heneghan, M. B., Parsons, S., Keller, F. G., Renfro, L., Pei, Q., Rodday, A., Wu, Y., Punnett, A., Belsky, J., Henderson, T. O., Kelly, K. M., & Castellino, S. (2024). Protocol-Stipulated Dose Modification to Manage Chemotherapy Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults with High-Risk Hodgkin Lymphoma. doi.org. https://doi.org/10.1200/OP.24.00089

Toxicity of BEP chemotherapy in germ cell tumors: focus on immune-mediated bleomycin pulmonary toxicity in comparison with EP and VIP regimens.

2026

Get citation

P, O., P, C., B, V., & K, R. (2026). Toxicity of BEP chemotherapy in germ cell tumors: focus on immune-mediated bleomycin pulmonary toxicity in comparison with EP and VIP regimens.. doi.org. https://doi.org/10.3389/fimmu.2026.1861834

Longitudinal plasma and urinary SP-D and sRAGE during BEP chemotherapy in germ cell tumours.

2026

Get citation

K, R., B, V., P, O., T, P., R, A., E, E., M, C., P, L., J, O., Z, O., P, P., Z, S., M, M., & P, C. (2026). Longitudinal plasma and urinary SP-D and sRAGE during BEP chemotherapy in germ cell tumours.. doi.org. https://doi.org/10.3389/fimmu.2026.1954888

What does the evidence say?

Receipt History

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work